Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20061
20071
20093
20121
20132
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation8
AstraZeneca1
Bayer1
CSL Behring1
ECRI bv1
Johns Hopkins University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease14
Acute Coronary Syndrome2
Atherosclerosis2
Cardiovascular Diseases2
Heart Diseases2
Myocardial Infarction2
Stroke2
Angina, Unstable1
Arterial Occlusive Diseases1
Arteriosclerosis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.